Evidence map›Paper›PMID 30453097›Full record

ReviewInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2019

Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Eskild Petersen, Ibrahim Abubakar, Chikwe Ihekweazu, David Heymann, Francine Ntoumi, Lucille Blumberg, Danny Asogun, Victor Mukonka, Swaib Abubaker Lule, Matthew Bates and 10 more

Abstract readEditorialReview
In one paragraph

Review in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Epidemiology and characteristics of cases with monkeypox virus clade I in the WHO European Region, 2024 to 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Eskild PetersenInstitute of Clinical Medicine, University of Aarhus, Denmark; The Royal Hospital, Muscat, Oman; ESCMID Emerging Infections Task Force, Basel, Switzerland. Electronic address: eskildp@dadlnet.dk.
Ibrahim AbubakarInstitute for Global Health, University College London, London, United Kingdom. Electronic address: i.abubakar@ucl.ac.uk.
Chikwe IhekweazuNigeria Centre for Disease Control, Jabi, Abuja, Nigeria. Electronic address: chikwe.ihekweazu@gmail.com.
David HeymannFaculty of Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: David.Heymann@lshtm.ac.uk.
Francine NtoumiUniversity Marien NGouabi and Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Congo. Electronic address: ffntoumi@hotmail.com.
Lucille BlumbergNational Institute for Communicable Diseases, Johannesburg, South Africa. Electronic address: lucilleb@nicd.ac.za.
Danny AsogunDepartment of Public Health, Faculty of Clinical Sciences, College of Medicine, Ambrose Alli University, Ekpoma, Nigeria. Electronic address: asogun2001@yahoo.com.
Victor MukonkaZambia National Public Health Institute, Ministry of Health, Lusaka, Zambia. Electronic address: vmukonka@gmail.com.
Swaib Abubaker LuleInstitute for Global Health, University College London, London, United Kingdom. Electronic address: swaiblule@gmail.com.
Matthew BatesHerpeZ and UNZA-UCLMS Project, University Teaching Hospital, Lusaka, Zambia; School of Life Sciences, University of Lincoln, Lincoln, United Kingdom. Electronic address: MBates@lincoln.ac.uk.
Isobella HoneyborneDivision of Infection and Immunity, Center for Clinical Microbiology, University College London, London, United Kingdom. Electronic address: i.honeyborne@ucl.ac.uk.
Sayoki MfinangaNational Institute of Medical Research Muhimbili, Dar es Salaam, Tanzania. Electronic address: gsmfinanga@yahoo.com.
Peter MwabaUNZA-UCLMS Project, and Lusaka Apex University Medical School, Lusaka, Zambia. Electronic address: pbmwaba2000@gmail.com.
Osman DarPublic Health England, London, United Kingdom; Chatham House Centre on Global Health Security, London, United Kingdom. Electronic address: Osman.Dar@phe.gov.uk.
Francesco VairoNational Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy. Electronic address: francesco.vairo@inmi.it.
Maowia MukhtarInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan. Electronic address: mmukhtar@tropmedicine.org.
Richard KockDepartment of Pathobiology and Population Sciences, The Royal Veterinary College, Hertfordshire, United Kingdom. Electronic address: rkock@rvc.ac.uk.
Timothy D McHughDivision of Infection and Immunity, Center for Clinical Microbiology, University College London, London, United Kingdom. Electronic address: t.mchugh@ucl.ac.uk.
Giuseppe IppolitoNational Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy. Electronic address: giuseppe.ippolito@inmi.it.
Alimuddin ZumlaDivision of Infection and Immunity, Center for Clinical Microbiology, University College London, United Kingdom; The National Institute of Health Research Biomedical Research Centre at UCL Hospitals, London, United Kingdom. Electronic address: a.zumla@ucl.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of monkeypox in 3 separate patients in the United Kingdom in September raised media and political attention on an emerging public health threat. Nigeria, whose last confirmed case of monkeypox was in 1978, is currently experiencing an unusually large and outbreak of human monkeypox cases, a 'One Human-Environmental-Animal Health' approach is being effectively used to define and tackle the outbreak. As of 13th October 2018, there have been one hundred and sixteen confirmed cases the majority of whom are under 40 years. Over the past 20 years ten Central and West African countries have reported monkeypox cases which have risen exponentially. We review the history and evolution of monkeypox outbreaks in Africa and USA, the changing clinical presentations, and discuss possible factors underlying the increasing numbers being detected including the cessation of smallpox vaccination programs. Major knowledge gaps remain on the epidemiology, host reservoir, and emergence, transmission, pathogenesis and prevention of monkeypoz.

Indexed as

Public HealthAnimalsDisease OutbreaksDisease ReservoirsEpidemicsHumansMpox, MonkeypoxSmallpoxVaccinationZoonoses

Identifiers

PMID30453097
PMCPMC7129336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.